Dr. Bohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Palo Alto, CA 94304Phone+1 650-723-7621- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1999 - 2001
- University of California San Francisco School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 1999 - 2025
Publications & Presentations
PubMed
- 1168 citationsLebrikizumab Treatment in Adults with AsthmaJonathan Corren, Robert F. Lemanske, Nicola A. Hanania, Phillip E. Korenblat, Merdad V. Parsey
The New England Journal of Medicine. 2011-09-21 - 16 citationsExpression profiles of adult T-cell leukemia–lymphoma and associations with clinical responses to zidovudine and interferon αAsh A. Alizadeh, Sean P. Bohen, Chen Lossos, Jose A. Martinez-Climent, Juan Carlos Ramos
Leukemia & Lymphoma. 2010-06-24 - 130 citationsLEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones.Anastasia Kralli, Sean P. Bohen, Keith R. Yamamoto
Proceedings of the National Academy of Sciences of the United States of America. 1995-05-09
Press Mentions
- Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 StudyMay 11th, 2023
- Olema Plans Pivotal Trial for Two-Prong Breast Cancer TreatmentJanuary 5th, 2023
- HER2 Breast Most Cancers Therapeutic, OP-1250, Receives Section 2 Dose SuggestionDecember 10th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: